Jean-Manasse Theagene - 17 Mar 2023 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Jean-Manasse Theagene
Issuer symbol
MAIA
Transactions as of
17 Mar 2023
Net transactions value
$0
Form type
3
Filing time
23 Mar 2023, 20:40:46 UTC
Next filing
04 Apr 2023

No securities are beneficially owned.